The NICTN and NI Cancer Research Consumer Forum (NICRCF) have released their post-consultation PPI strategy for cancer research in NI.  This updates the strategy originally launched last year.  The NI[...Read More]

Patient safety remains a priority of the NICTN.  At the outset of the local COVID-19 crisis NICTN suspended recruitment to the majority of clinical trials and other research studies.  In alignment wit[...Read More]